Stockreport

CG Oncology (CGON) Is Up 29.7% After Accelerating PIVOT-006 Phase 3 Timeline - Has The Bull Case Changed? [Yahoo! Finance]

CG Oncology, Inc. - Common stock  (CGON) 
PDF non-muscle invasive bladder cancer will now be available in the first half of 2026, nearly a year earlier than originally planned due to rapid enrollment across more tha [Read more]